Covered recipient · General Payments record
BELLA ZIMILEVICH
Allopathic & Osteopathic Physicians Internal Medicine Geriatric Medicine
General Payments · PY2018–2024
$1,370.94
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $260.03 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $80.89 | 3 |
| Novo Nordisk AS | $53.13 | 2 |
| Amgen Inc. | $46.04 | 2 |
| Vanda Pharmaceuticals Inc. | $33.22 | 1 |
| ABBVIE INC. | $25.70 | 1 |
| Acerta Pharma LLC | $21.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.70 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106398297 | CMS |
| Amgen Inc. | $21.98 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117422872 | CMS |
| Amgen Inc. | $24.06 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117422874 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.05 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104591878 | CMS |
| Lilly USA, LLC | $25.64 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136064572 | CMS |
| Lilly USA, LLC | $25.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136075923 | CMS |
| Lilly USA, LLC | $30.25 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136065662 | CMS |
| Novo Nordisk Inc | $24.92 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096756936 | CMS |
| Novo Nordisk Inc | $28.21 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096633321 | CMS |
| Vanda Pharmaceuticals Inc. | $33.22 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133927650 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.